【調査レポート】創傷治癒のグローバル市場（2023年-2031年）：ドレッシング、包帯、外用剤、創傷被覆剤、その他

• 英文タイトル：Wound Healing Market (Product: Dressings, Bandages, Topical Agents, Wound Closure Agents, Gauzes & Sponges, Tapes, Therapy Devices, and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2023-2031

Transparency Market Researchが調査・発行した産業分析レポートです。創傷治癒のグローバル市場（2023年-2031年）：ドレッシング、包帯、外用剤、創傷被覆剤、その他 / Wound Healing Market (Product: Dressings, Bandages, Topical Agents, Wound Closure Agents, Gauzes & Sponges, Tapes, Therapy Devices, and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2023-2031 / MRC2403B302資料のイメージです。

• レポートコード：MRC2403B302
• 出版社/出版日：Transparency Market Research / 2024年1月
• レポート形態：英文、PDF、352ページ
• 納品方法：受注後3営業日
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥869,250 (USD5,795)	▷ お問い合わせ
Multi User	￥1,319,250 (USD8,795)	▷ お問い合わせ
Corporate License	￥1,769,250 (USD11,795)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

創傷治癒市場 - レポートの範囲TMRの世界創傷治癒市場に関する調査レポートは、2023年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会を調査しています。2023年を基準年、2031年を予測年として、2017年から2031年までの世界の創傷治癒市場の収益を提供しています。また、2023年から2031年までの世界の創傷治癒市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されました。主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。二次調査では、創傷治癒市場を理解するために、主要企業の製品資料、年次報告書、プレスリリース、関連文書を参照しました。

二次調査にはインターネット情報源、政府機関の統計データ、ウェブサイト、業界団体なども含まれます。アナリストはトップダウンアプローチとボトムアップアプローチを組み合わせて、世界の創傷治癒市場の様々な属性を調査しました。

本レポートには、調査範囲に含まれる様々なセグメントの成長動向のスナップショットとともに、詳細なエグゼクティブサマリーが含まれています。さらに、世界の創傷治癒市場における競争ダイナミクスの変化にも光を当てています。これらは、既存の市場プレイヤーだけでなく、世界の創傷治癒市場への参入に関心のある企業にとっても貴重なツールとなります。

本レポートでは、世界の創傷治癒市場の競争環境について掘り下げています。世界の創傷治癒市場で事業を展開する主要企業が特定され、それぞれの企業が様々な属性の観点からプロファイリングされています。会社概要、財務状況、最近の動向、SWOTは、本レポートで紹介されている世界の創傷治癒市場におけるプレイヤーの属性です。

創傷治癒の世界市場レポートが回答した主な質問
- 予測期間中の全地域における創傷治癒が生み出す売上高/収益は？
- 世界の創傷治癒市場におけるビジネスチャンスは？
- 市場の主な促進要因、阻害要因、機会、脅威は何か？
- 予測期間中に最も速いCAGRで拡大する地域市場はどこか？
- 2031年に世界で最も高い収益を上げると予測されるセグメントは？
- 予測期間中に最も高いCAGRで拡大すると予測されるセグメントは？
- 世界市場で事業を展開する各企業の市場ポジションは？

創傷治癒市場 - 調査目的と調査アプローチ
創傷治癒の世界市場に関する包括的なレポートは、概要から始まり、調査範囲と目的が続きます。本レポートでは、本調査の目的、市場で事業を展開する主要ベンダーと販売業者、製品承認に関する規制シナリオについて詳細に解説しています。

本レポートは、読みやすさを考慮し、各セクションを章ごとに分割したレイアウトになっています。本レポートは、グラフや表が適切に散りばめられた網羅的なコレクションで構成されています。主要セグメントの実績値と予測値を図式化し、読者に視覚的に訴えます。また、過去と予測期間末の主要セグメントの市場シェアの比較も可能です。

本レポートでは、世界の創傷治癒市場を製品、エンドユーザー、地域の観点から分析しています。各基準における主要セグメントを詳細に調査し、2031年末時点の各セグメントにおける市場シェアを掲載しています。このような貴重な洞察により、市場関係者は世界の創傷治癒市場への投資について十分な情報に基づいたビジネス上の意思決定を行うことができます。

1. エグゼクティブサマリー
2. 仮定・調査手法
3. エグゼクティブサマリー：世界の創傷治癒市場
4. 市場概要
5. 主要インサイト
6. 創傷治癒市場分析・予測：製品別
7. 世界の創傷治癒市場分析・予測：創傷タイプ別
8. 世界の創傷治癒市場分析・予測：地域別
9. 北米の創傷治癒市場分析・予測
10. ヨーロッパの創傷治癒市場分析・予測
11. アジア太平洋の創傷治癒市場分析・予測
12. 中南米の創傷治癒市場分析・予測
13. 中東/アフリカの創傷治癒市場分析・予測
14. 競争状況

レポート目次

1. Executive Summary
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Wound Healing Market
4. Market Overview
4.1. Market Segmentation
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Wound Healing Market Analysis and Forecasts, 2017-2031
5. Key Insights
5.1. Pipeline Analysis
5.2. COVID-19 Pandemic Impact on Industry
6. Wound Healing Market Analysis and Forecast, by Product
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Dressings
6.3.1.1. Foam Dressings
6.3.1.2. Hydrocolloid Dressings
6.3.1.3. Hydrogel Dressings
6.3.1.4. Alginate Dressings
6.3.1.5. Collagen Dressings
6.3.1.6. Others
6.3.2. Bandages
6.3.2.1. Elastic Bandages
6.3.2.2. Compression Bandages
6.3.2.3. Adhesive Bandages
6.3.2.4. Liquid Bandages
6.3.2.5. Others
6.3.3. Topical Agents
6.3.3.1. Hemostatic Agents
6.3.3.2. Antimicrobials
6.3.3.3. Wound Cleansers
6.3.3.4. Others
6.3.4. Wound Closure Agents
6.3.4.1. Sutures
6.3.4.1.1. Absorbable
6.3.4.1.2. Non-absorbable
6.3.4.2. Adhesives & Sealants
6.3.4.3. Staplers
6.3.4.3.1. Manual
6.3.4.3.2. Powered
6.3.4.4. Strips
6.3.4.4.1. Sterile
6.3.4.4.2. Non-sterile
6.3.4.5. Others
6.3.5. Gauzes & Sponges
6.3.5.1. Sterile
6.3.5.2. Non-sterile
6.3.6. Tapes
6.3.6.1. Cloth Tapes
6.3.6.2. Paper Tapes
6.3.6.3. Silicon Tapes
6.3.7. Others
6.3.8. Therapy Devices
6.3.8.1. Negative Pressure Wound Therapy Devices
6.3.8.2. Oxygen Therapy Devices
6.3.8.3. Others (Electro-magnetic Wound Therapy Devices)
6.3.9. Others
6.4. Market Attractiveness, by Product
7. Global Wound Healing Market Analysis and Forecast, by Wound Type
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Wound Type, 2017–2031
7.3.1. Acute Wound
7.3.1.1. Surgical & Traumatic Wounds
7.3.1.2. Burns
7.3.2. Chronic Wound
7.3.2.1. Infectious Wounds & Other Ischemic Wounds
7.3.2.2. Ulcers
7.3.2.2.1. Pressure Ulcers
7.3.2.2.2. Diabetic Foot Ulcers
7.3.2.2.3. Arterial & Venous Ulcers
7.3.2.2.4. Others
7.4. Market Attractiveness, by Wound Type
8. Global Wound Healing Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region, 2017–2031
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness, by Region
9. North America Wound Healing Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product, 2017–2031
9.2.1. Dressings
9.2.1.1. Foam Dressings
9.2.1.2. Hydrocolloid Dressings
9.2.1.3. Hydrogel Dressings
9.2.1.4. Alginate Dressings
9.2.1.5. Collagen Dressings
9.2.1.6. Others
9.2.2. Bandages
9.2.2.1. Elastic Bandages
9.2.2.2. Compression Bandages
9.2.2.3. Adhesive Bandages
9.2.2.4. Liquid Bandages
9.2.2.5. Others
9.2.3. Topical Agents
9.2.3.1. Hemostatic Agents
9.2.3.2. Antimicrobials
9.2.3.3. Wound Cleansers
9.2.3.4. Others
9.2.4. Wound Closure Agents
9.2.4.1. Sutures
9.2.4.1.1. Absorbable
9.2.4.1.2. Non-absorbable
9.2.4.2. Adhesives & Sealants
9.2.4.3. Staplers
9.2.4.3.1. Manual
9.2.4.3.2. Powered
9.2.4.4. Strips
9.2.4.4.1. Sterile
9.2.4.4.2. Non-sterile
9.2.4.5. Others
9.2.5. Gauzes & Sponges
9.2.5.1. Sterile
9.2.5.2. Non-sterile
9.2.6. Tapes
9.2.6.1. Cloth Tapes
9.2.6.2. Paper Tapes
9.2.6.3. Silicon Tapes
9.2.7. Others
9.2.8. Therapy Devices
9.2.8.1. Negative Pressure Wound Therapy Devices
9.2.8.2. Oxygen Therapy Devices
9.2.8.3. Others (Electro-magnetic Wound Therapy Devices)
9.2.9. Others
9.3. Market Value Forecast, by Wound Type, 2017–2031
9.3.1. Acute Wound
9.3.1.1. Surgical & Traumatic Wounds
9.3.1.2. Burns
9.3.2. Chronic Wound
9.3.2.1. Infectious Wounds & Other Ischemic Wounds
9.3.2.2. Ulcers
9.3.2.2.1. Pressure Ulcers
9.3.2.2.2. Diabetic Foot Ulcers
9.3.2.2.3. Arterial & Venous Ulcers
9.3.2.2.4. Others
9.4. Market Value Forecast, by Country, 2017–2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By Wound Type
9.5.3. By Country
10. Europe Wound Healing Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017–2031
10.2.1. Dressings
10.2.1.1. Foam Dressings
10.2.1.2. Hydrocolloid Dressings
10.2.1.3. Hydrogel Dressings
10.2.1.4. Alginate Dressings
10.2.1.5. Collagen Dressings
10.2.1.6. Others
10.2.2. Bandages
10.2.2.1. Elastic Bandages
10.2.2.2. Compression Bandages
10.2.2.3. Adhesive Bandages
10.2.2.4. Liquid Bandages
10.2.2.5. Others
10.2.3. Topical Agents
10.2.3.1. Hemostatic Agents
10.2.3.2. Antimicrobials
10.2.3.3. Wound Cleansers
10.2.3.4. Others
10.2.4. Wound Closure Agents
10.2.4.1. Sutures
10.2.4.1.1. Absorbable
10.2.4.1.2. Non-absorbable
10.2.4.2. Adhesives & Sealants
10.2.4.3. Staplers
10.2.4.3.1. Manual
10.2.4.3.2. Powered
10.2.4.4. Strips
10.2.4.4.1. Sterile
10.2.4.4.2. Non-sterile
10.2.4.5. Others
10.2.5. Gauzes & Sponges
10.2.5.1. Sterile
10.2.5.2. Non-sterile
10.2.6. Tapes
10.2.6.1. Cloth Tapes
10.2.6.2. Paper Tapes
10.2.6.3. Silicon Tapes
10.2.7. Others
10.2.8. Therapy Devices
10.2.8.1. Negative Pressure Wound Therapy Devices
10.2.8.2. Oxygen Therapy Devices
10.2.8.3. Others (Electro-magnetic Wound Therapy Devices)
10.2.9. Others
10.3. Market Value Forecast, by Wound Type, 2017–2031
10.3.1. Acute Wound
10.3.1.1. Surgical & Traumatic Wounds
10.3.1.2. Burns
10.3.2. Chronic Wound
10.3.2.1. Infectious Wounds & Other Ischemic Wounds
10.3.2.2. Ulcers
10.3.2.2.1. Pressure Ulcers
10.3.2.2.2. Diabetic Foot Ulcers
10.3.2.2.3. Arterial & Venous Ulcers
10.3.2.2.4. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017–2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By Wound Type
10.5.3. By Country/Sub-region
11. Asia Pacific Wound Healing Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017–2031
11.2.1. Dressings
11.2.1.1. Foam Dressings
11.2.1.2. Hydrocolloid Dressings
11.2.1.3. Hydrogel Dressings
11.2.1.4. Alginate Dressings
11.2.1.5. Collagen Dressings
11.2.1.6. Others
11.2.2. Bandages
11.2.2.1. Elastic Bandages
11.2.2.2. Compression Bandages
11.2.2.3. Adhesive Bandages
11.2.2.4. Liquid Bandages
11.2.2.5. Others
11.2.3. Topical Agents
11.2.3.1. Hemostatic Agents
11.2.3.2. Antimicrobials
11.2.3.3. Wound Cleansers
11.2.3.4. Others
11.2.4. Wound Closure Agents
11.2.4.1. Sutures
11.2.4.1.1. Absorbable
11.2.4.1.2. Non-absorbable
11.2.4.2. Adhesives & Sealants
11.2.4.3. Staplers
11.2.4.3.1. Manual
11.2.4.3.2. Powered
11.2.4.4. Strips
11.2.4.4.1. Sterile
11.2.4.4.2. Non-sterile
11.2.4.5. Others
11.2.5. Gauzes & Sponges
11.2.5.1. Sterile
11.2.5.2. Non-sterile
11.2.6. Tapes
11.2.6.1. Cloth Tapes
11.2.6.2. Paper Tapes
11.2.6.3. Silicon Tapes
11.2.7. Others
11.2.8. Therapy Devices
11.2.8.1. Negative Pressure Wound Therapy Devices
11.2.8.2. Oxygen Therapy Devices
11.2.8.3. Others (Electro-magnetic Wound Therapy Devices)
11.2.9. Others
11.3. Market Value Forecast, by Wound Type, 2017–2031
11.3.1. Acute Wound
11.3.1.1. Surgical & Traumatic Wounds
11.3.1.2. Burns
11.3.2. Chronic Wound
11.3.2.1. Infectious Wounds & Other Ischemic Wounds
11.3.2.2. Ulcers
11.3.2.2.1. Pressure Ulcers
11.3.2.2.2. Diabetic Foot Ulcers
11.3.2.2.3. Arterial & Venous Ulcers
11.3.2.2.4. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017–2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By Wound Type
11.5.3. By Country/Sub-region
12. Latin America Wound Healing Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2031
12.2.1. Dressings
12.2.1.1. Foam Dressings
12.2.1.2. Hydrocolloid Dressings
12.2.1.3. Hydrogel Dressings
12.2.1.4. Alginate Dressings
12.2.1.5. Collagen Dressings
12.2.1.6. Others
12.2.2. Bandages
12.2.2.1. Elastic Bandages
12.2.2.2. Compression Bandages
12.2.2.3. Adhesive Bandages
12.2.2.4. Liquid Bandages
12.2.2.5. Others
12.2.3. Topical Agents
12.2.3.1. Hemostatic Agents
12.2.3.2. Antimicrobials
12.2.3.3. Wound Cleansers
12.2.3.4. Others
12.2.4. Wound Closure Agents
12.2.4.1. Sutures
12.2.4.1.1. Absorbable
12.2.4.1.2. Non-absorbable
12.2.4.2. Adhesives & Sealants
12.2.4.3. Staplers
12.2.4.3.1. Manual
12.2.4.3.2. Powered
12.2.4.4. Strips
12.2.4.4.1. Sterile
12.2.4.4.2. Non-sterile
12.2.4.5. Others
12.2.5. Gauzes & Sponges
12.2.5.1. Sterile
12.2.5.2. Non-sterile
12.2.6. Tapes
12.2.6.1. Cloth Tapes
12.2.6.2. Paper Tapes
12.2.6.3. Silicon Tapes
12.2.7. Others
12.2.8. Therapy Devices
12.2.8.1. Negative Pressure Wound Therapy Devices
12.2.8.2. Oxygen Therapy Devices
12.2.8.3. Others (Electro-magnetic Wound Therapy Devices)
12.2.9. Others
12.3. Market Value Forecast, by Wound Type, 2017–2031
12.3.1. Acute Wound
12.3.1.1. Surgical & Traumatic Wounds
12.3.1.2. Burns
12.3.2. Chronic Wound
12.3.2.1. Infectious Wounds & Other Ischemic Wounds
12.3.2.2. Ulcers
12.3.2.2.1. Pressure Ulcers
12.3.2.2.2. Diabetic Foot Ulcers
12.3.2.2.3. Arterial & Venous Ulcers
12.3.2.2.4. Others
12.4. Market Value Forecast, by Country/Sub-region, 2017–2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By Wound Type
12.5.3. By Country/Sub-region
13. Middle East & Africa Wound Healing Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017–2031
13.2.1. Dressings
13.2.1.1. Foam Dressings
13.2.1.2. Hydrocolloid Dressings
13.2.1.3. Hydrogel Dressings
13.2.1.4. Alginate Dressings
13.2.1.5. Collagen Dressings
13.2.1.6. Others
13.2.2. Bandages
13.2.2.1. Elastic Bandages
13.2.2.2. Compression Bandages
13.2.2.3. Adhesive Bandages
13.2.2.4. Liquid Bandages
13.2.2.5. Others
13.2.3. Topical Agents
13.2.3.1. Hemostatic Agents
13.2.3.2. Antimicrobials
13.2.3.3. Wound Cleansers
13.2.3.4. Others
13.2.4. Wound Closure Agents
13.2.4.1. Sutures
13.2.4.1.1. Absorbable
13.2.4.1.2. Non-absorbable
13.2.4.2. Adhesives & Sealants
13.2.4.3. Staplers
13.2.4.3.1. Manual
13.2.4.3.2. Powered
13.2.4.4. Strips
13.2.4.4.1. Sterile
13.2.4.4.2. Non-sterile
13.2.4.5. Others
13.2.5. Gauzes & Sponges
13.2.5.1. Sterile
13.2.5.2. Non-sterile
13.2.6. Tapes
13.2.6.1. Cloth Tapes
13.2.6.2. Paper Tapes
13.2.6.3. Silicon Tapes
13.2.7. Others
13.2.8. Therapy Devices
13.2.8.1. Negative Pressure Wound Therapy Devices
13.2.8.2. Oxygen Therapy Devices
13.2.8.3. Others (Electro-magnetic Wound Therapy Devices)
13.2.9. Others
13.3. Market Value Forecast, by Wound Type, 2017–2031
13.3.1. Acute Wound
13.3.1.1. Surgical & Traumatic Wounds
13.3.1.2. Burns
13.3.2. Chronic Wound
13.3.2.1. Infectious Wounds & Other Ischemic Wounds
13.3.2.2. Ulcers
13.3.2.2.1. Pressure Ulcers
13.3.2.2.2. Diabetic Foot Ulcers
13.3.2.2.3. Arterial & Venous Ulcers
13.3.2.2.4. Others
13.4. Market Value Forecast, by Country/Sub-region, 2017–2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By Wound Type
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of Companies)
14.2. Market Share Analysis, by Company (2022)
14.3. Company Profiles
14.3.1. Baxter
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. Financial Overview
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. Medical Devices Business Services, Inc.
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. Financial Overview
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. Mölnlycke Health Care AB
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Portfolio
14.3.3.3. Financial Overview
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. 3M
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. Financial Overview
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. Integra LifeSciences
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. Financial Overview
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
14.3.6. Smith & Nephew
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Product Portfolio
14.3.6.3. Financial Overview
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. Cardinal Health
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Product Portfolio
14.3.7.3. Financial Overview
14.3.7.4. SWOT Analysis
14.3.7.5. Strategic Overview
14.3.8. B. Braun SE
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Product Portfolio
14.3.8.3. Financial Overview
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
14.3.9. Convatec Group PLC
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Product Portfolio
14.3.9.3. Financial Overview
14.3.9.4. SWOT Analysis
14.3.9.5. Strategic Overview
14.3.10. Svenska Cellulosa Aktiebolaget SCA (publ)
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Product Portfolio
14.3.10.3. Financial Overview
14.3.10.4. SWOT Analysis
14.3.10.5. Strategic Overview
14.3.11. Coloplast Group
14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.11.2. Product Portfolio
14.3.11.3. Financial Overview
14.3.11.4. SWOT Analysis
14.3.11.5. Strategic Overview
14.3.12. Hill-Rom Holdings, Inc.
14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.12.2. Product Portfolio
14.3.12.3. Financial Overview
14.3.12.4. SWOT Analysis
14.3.12.5. Strategic Overview
14.3.13. Medline Industries, Inc.
14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.13.2. Product Portfolio
14.3.13.3. Financial Overview
14.3.13.4. SWOT Analysis
14.3.13.5. Strategic Overview
14.3.14. Hollister Incorporated
14.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.14.2. Product Portfolio
14.3.14.3. Financial Overview
14.3.14.4. SWOT Analysis
14.3.14.5. Strategic Overview